Drug Type Monoclonal antibody |
Synonyms CAN 107, CAN107 |
Target |
Mechanism FGF23 antagonists(Fibroblast growth factor 23 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Familial Hypophosphatemic Rickets | Preclinical | CN | 01 Dec 2024 | |
Rickets, Hypophosphatemic | Preclinical | CN | 30 Jan 2022 |